Mediators and moderators of treatment effects in randomized clinical trials.

Randomized clinical trials (RCTs) not only are the gold standard for evaluating the efficacy and effectiveness of psychiatric treatments but also can be valuable in revealing moderators and mediators of therapeutic change. Conceptually, moderators identify on whom and under what circumstances treatments have different effects. Mediators identify why and how treatments have effects. We describe an analytic framework to identify and distinguish between moderators and mediators in RCTs when outcomes are measured dimensionally. Rapid progress in identifying the most effective treatments and understanding on whom treatments work and do not work and why treatments work or do not work depends on efforts to identify moderators and mediators of treatment outcome. We recommend that RCTs routinely include and report such analyses.

[1]  R. Shephard Regression to the Mean , 2003, Sports medicine.

[2]  H. Kraemer,et al.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. , 2001, The American journal of psychiatry.

[3]  R. Longabaugh,et al.  Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. , 2000, Addiction.

[4]  H. Kraemer,et al.  A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. , 2000, Archives of general psychiatry.

[5]  S. Hyman The millennium of mind, brain, and behavior. , 2000, Archives of general psychiatry.

[6]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[7]  Alan E. Kazdin,et al.  Measuring the potency of risk factors for clinical or policy significance. , 1999 .

[8]  E. Petkova,et al.  Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change. , 1999, Journal of consulting and clinical psychology.

[9]  J. Swanson,et al.  Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. , 1999, Archives of general psychiatry.

[10]  E. Smeraldi,et al.  Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine , 1998, Molecular Psychiatry.

[11]  J. Weisz,et al.  Identifying and developing empirically supported child and adolescent treatments. , 1998, Journal of consulting and clinical psychology.

[12]  J. Geller,et al.  What Works for Whom? A Critical Review of Psychotherapy Research , 1997 .

[13]  G. Holmbeck Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators : examples from the child-clinical and pediatric psychology literatures , 1997 .

[14]  Stephen M Stigler,et al.  Regression towards the mean, historically considered , 1997, Statistical methods in medical research.

[15]  H. Kraemer,et al.  Coming to terms with the terms of risk. , 1997, Archives of general psychiatry.

[16]  Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. , 1997, Journal of studies on alcohol.

[17]  G. Holmbeck Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures. , 1997, Journal of consulting and clinical psychology.

[18]  W. E. Craighead,et al.  The Role of Nonspecific Factors in Cognitive‐Behavior Therapy for Depression , 1994 .

[19]  C. Diclemente,et al.  Issues in the development of client-treatment matching hypotheses. , 1994, Journal of studies on alcohol. Supplement.

[20]  C R Bauer,et al.  Early intervention in low-birth-weight premature infants. Results through age 5 years from the Infant Health and Development Program. , 1994 .

[21]  M Borenstein,et al.  The case for confidence intervals in controlled clinical trials. , 1994, Controlled clinical trials.

[22]  D. Altman,et al.  Statistic Notes: Regression towards the mean , 1994, BMJ.

[23]  R. Rosenthal Parametric measures of effect size. , 1994 .

[24]  M. Whisman Mediators and moderators of change in cognitive therapy of depression , 1993 .

[25]  H. Kraemer Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance , 1992, Psychoneuroendocrinology.

[26]  L M LaVange,et al.  Infant Health and Development Program for low birth weight, premature infants: program elements, family participation, and child intelligence. , 1992, Pediatrics.

[27]  M. L. Samuels,et al.  Statistical Reversion Toward the Mean: More Universal Than Regression Toward the Mean , 1991 .

[28]  W. Agras,et al.  Mechanisms of action in cognitive-behavioral and pharmacological interventions for obesity and bulimia nervosa. , 1991, Journal of consulting and clinical psychology.

[29]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[30]  W M Grove,et al.  How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. , 1990, Journal of consulting and clinical psychology.

[31]  Laurence H. Baker,et al.  Clinical Trials: Design, Conduct, and Analysis , 1987 .

[32]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[33]  L. Hedges Estimation and testing for differences in effect size: A comment on Hsu. , 1982 .

[34]  C. Meinert Toward more definitive clinical trials. , 1980, Controlled clinical trials.

[35]  C. E. Davis,et al.  The effect of regression to the mean in epidemiologic and clinical studies. , 1976, American journal of epidemiology.